Society for Clinical Research Sites Announces Additional Commitment from INC Research for Global Site Engagement Initiatives
Contact:
Amanda Ascoli
Communications Associate
Society for Clinical Research Sites
410.696.5080 x120
amanda.ascoli@myscrs.org
Society for Clinical Research Sites Announces Additional Commitment from INC Research for Global Site Engagement Initiatives
Global CRO reinforces commitment to key stakeholder group as title sponsor for site appreciation events at U.S. and European Summits
Ellicott City, MD, Aug. 18, 2014 — The Society for Clinical Research Sites (SCRS), the trade organization representing over 1,500 global clinical research sites in 37 countries, today announced that INC Research, a leading, global Phase I to IV clinical research organization (CRO), will sponsor site appreciation events at the society’s annual Site Solutions Summit, taking place Oct. 10-12, 2014, on Amelia Island, Fla. and its inaugural European Summit to be held March 25-27, 2015, in Croatia. INC Research, an SCRS Global Impact Partner, has been actively engaged in supporting the efforts of the society, as well as site engagement overall, through a number of initiatives connecting sites, sponsors and CROs in an ongoing dialogue regarding how to work together more effectively to improve the clinical development process for the benefit of patients.
“We are excited to partner further with INC Research and appreciate its continued support in fostering strong relationships with clinical research sites globally,” stated Christine Pierre, President, SCRS. “Our Site Solutions Summit is an important forum for parties to engage and collaborate to create lasting partnerships that will provide a more effective and efficient drug development industry. The addition of the INC Research appreciation events to our U.S. and European programs will provide further opportunity to continue the ongoing dialogue with sites globally in support of this objective.”
SCRS’ Site Solutions Summit provides a unique platform for dialogue, development, and efficiency improvement across all organizations in the clinical research enterprise. More than 600 attendees representing nearly 100 sponsor/CRO organizations and sites will participate. General session topics will cover factors impacting sites, adaptive solutions around data and recruitment, technology innovation and operations benchmarks from the SCRS site survey. INC Research’s site appreciation event at the U.S. meeting will follow the ceremony recognizing the recipients of the annual SCRS Eagle Award, which honors one sponsor and one CRO that best exemplify great site relationships.
“INC Research values the important contributions our site partners make to the clinical research process,” said Jamie Macdonald, CEO, INC Research. “Our continued involvement with SCRS and participation in the Site Solutions Summit is invaluable in providing yet another forum for us to connect with this key stakeholder group. Engaging in an ongoing dialogue with our clinical research sites enables us to better understand their needs and collaborate more effectively in bringing new drug therapies to the market.”
For more information on the U.S. Site Solutions Summit or to register to attend, please visit www.SiteSolutionsSummit.com or MySCRS.org. To visit the SCRS Video Channel, search “mySCRS.org” on YouTube or connect with us on Twitter @mySCRS and #scrs14.
About SCRS
SCRS is a global trade organization founded in 2012 which represents over 1,500 research sites, including 13,000 Investigators in 37 countries. SCRS’ mission is to unify the voice of the global clinical research site community for site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership. Visit MySCRS.org.
About INC Research
INC Research is a leading global contract research organization (CRO) providing the full range of Phase I to Phase IV clinical development services for the world’s biopharmaceutical and medical device industry. As a therapeutically focused CRO, with a Trusted Process® delivery methodology, developing the medicines people need is something we take personally. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market to improve world health. We were ranked “Top CRO to Work With” by sites worldwide in the 2013 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC, with operations across six continents and experience spanning more than 100 countries. For more information, please visit www.incresearch.com and connect with us on LinkedIn and Twitter @inc_research.
# # #
